With the click of a button, The Identifier System could have quickly tracked and traced the origin of the Pfizer-BioNTech vaccine defects and its distribution trail. On March 23, 2021, Hong Kong puts a stop on distributing the Pfizer-BioNTech Vaccine to residents. Many containers were flawed among a batch of 585,000 doses due to packaging…
Read more
Visible Particulate Matter in Single-Use Bags
In an article published by BioProcess International, visible particulate matter in single-use systems (SUS) is stated to be a big concern. SUS is a product/equipment designed to be used once; it is primarily composed of plastic that can be discarded easily. It is necessary when creating products with SUS, the parenteral drugs must be “essentially…
Read more
Parenterals, Particulates, and Quality by Design
Particulate matter in parenteral drugs has been a known issue for over two centuries. Particular matter could come from any little thing that is involved in the process of making the drug product. Contaminants could come from the environment, packaging for the product, ingredients in the product, reactions of the formula and anything that could…
Read more
Improving Visual Inspection Practices
Improving Visual Inspection Practices, written by Jennifer Markarian with Pharmaceutical Technology, she interviews John Shabushnig, PhD and talks about the need of improving the understanding and practice of visual inspection of parenteral drugs. Their interview gives guidance of where to search for help, as well as what is recommended. PDA and USP have been working together…
Read more